Your browser doesn't support javascript.
loading
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC.
Schwartzberg, Lee S; Li, Gerald; Tolba, Khaled; Bourla, Ariel B; Schulze, Katja; Gadgil, Rujuta; Fine, Alexander; Lofgren, Katherine T; Graf, Ryon P; Oxnard, Geoffrey R; Daniel, Davey.
Afiliação
  • Schwartzberg LS; West Cancer Center, Medical Director, Germantown, Tennessee.
  • Li G; Foundation Medicine, Clinical Development, Cambridge, Massachusetts.
  • Tolba K; Foundation Medicine, Clinical Development, Cambridge, Massachusetts.
  • Bourla AB; Flatiron Health, Medical Director, New York, New York.
  • Schulze K; Genentech, Inc., Oncology Biomarker Development & Medical Affairs, South San Francisco, California.
  • Gadgil R; Foundation Medicine, Clinical Operations, Cambridge, Massachusetts.
  • Fine A; Foundation Medicine, Cancer Genomics Research, Cambridge, Massachusetts.
  • Lofgren KT; Foundation Medicine, Decision Sciences, Cambridge, Massachusetts.
  • Graf RP; Foundation Medicine, Clinical Development, Cambridge, Massachusetts.
  • Oxnard GR; Foundation Medicine, Clinical Development, Cambridge, Massachusetts.
  • Daniel D; Tennessee Oncology, Medical Oncology, Chattanooga, Tennessee.
JTO Clin Res Rep ; 3(9): 100386, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36089920
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article